Randal W Scott Insider Trading
Get free email notifications about insider trading for Randal W Scott.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Randal W Scott. Randal W Scott is a Chairman and CEO in GENOMIC HEALTH INC ($GHDX) and an Chief Executive Officer in GENOMIC HEALTH INC ($GHDX) and a Chairman and CEO in Invitae Corp ($NVTA) and an Executive Chairman in Invitae Corp ($NVTA) and a Director in Talis Biomedical Corp ($TLIS) and a Director in BridgeBio Pharma, Inc. ($BBIO).
Address: 301 PENOBSCOT DRIVE REDWOOD CITY 94063 CA
Companies in which Randal W Scott is an Insider
BridgeBio Pharma, Inc.
Trading Symbol: BBIOIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Randal W Scott: Director
Holdings: 0 shares
Latest Transaction: Jun 25 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
GENOMIC HEALTH INC
Trading Symbol: GHDXIndustry: SERVICES-MEDICAL LABORATORIES [8071]
Position of Randal W Scott: Chief Executive Officer, Chairman and CEO
Holdings: 2,171,299 shares
Current Value: $59,689,010
Latest Transaction: Jun 20 2007
$GHDX Market Capitalization: $928.37M
$GHDX Previous Close: $27.49
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Invitae Corp
Trading Symbol: NVTAIndustry: SERVICES-MEDICAL LABORATORIES [8071]
Position of Randal W Scott: Executive Chairman, Chairman and CEO
Holdings: 3,478,970 shares
Current Value: $30,614,936
Latest Transaction: Aug 27 2019
$NVTA Market Capitalization: $281.95M
$NVTA Previous Close: $8.80
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Talis Biomedical Corp
Trading Symbol: TLISIndustry: LABORATORY ANALYTICAL INSTRUMENTS [3826]
Position of Randal W Scott: Director
Holdings: 9,000 shares
Latest Transaction: May 18 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Randal W Scott
Sentiment: All, BBIO, GHDX, NVTA, TLIS
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 18 2021 | TLIS | Talis Biomedical C ... | Scott Randal W. | Director | Buy | P | 10.11 | 11,000 | 111,210 | 20,000 | 9 K to 20 K (+122.22 %) |
May 18 2021 | TLIS | Talis Biomedical C ... | Scott Randal W. | Director | Buy | P | 10.16 | 9,000 | 91,440 | 9,000 | 0 to 9 K |
Feb 19 2021 | TLIS | Talis Biomedical C ... | Scott Randal W. | Director | Option Exercise | C | 0.00 | 432,749 | 0 | 0 | |
Feb 19 2021 | TLIS | Talis Biomedical C ... | Scott Randal W. | Director | Option Exercise | C | 0.00 | 478,402 | 0 | 0 | |
Feb 19 2021 | TLIS | Talis Biomedical C ... | Scott Randal W. | Director | Option Exercise | C | 0.00 | 1,076,643 | 0 | 0 | |
Feb 19 2021 | TLIS | Talis Biomedical C ... | Scott Randal W. | Director | Buy | P | 16.00 | 312,500 | 5,000,000 | 312,500 | 0 to 312.5 K |
Feb 19 2021 | TLIS | Talis Biomedical C ... | Scott Randal W. | Director | Buy | C | 0.00 | 302,621 | 0 | 1,390,064 | 1.1 M to 1.4 M (+27.83 %) |